Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey.

Michael T RichardsonKristopher AttwoodGabriella SmithSu-Ying LiangKatherine LaVigne MagerKrishnansu S TewariRobert L ColemanDaniel S KappJohn K ChanBradley J Monk

Published in: Cancer control : journal of the Moffitt Cancer Center (2023)

The combination of immunotherapies and biologics have significantly increased overall survival, but with associated higher costs, primarily related to drug costs.

Keyphrases

squamous cell carcinoma
small cell lung cancer
case report
emergency department
adverse drug